Indirect comparison of randomised controlled trials: comparative efficacy of dexlansoprazole vs. esomeprazole in the treatment of gastro-oesophageal reflux disease.

@article{Wu2013IndirectCO,
  title={Indirect comparison of randomised controlled trials: comparative efficacy of dexlansoprazole vs. esomeprazole in the treatment of gastro-oesophageal reflux disease.},
  author={Ming-Shiang Wu and Shwu Chuin Tan and Tao Xiong},
  journal={Alimentary pharmacology & therapeutics},
  year={2013},
  volume={38 2},
  pages={190-201}
}
BACKGROUND Dexlansoprazole is a new proton pump inhibitor (PPI) with a dual delayed-release system. Both dexlansoprazole and esomeprazole are an enantiomer of lansoprazole and omeprazole respectively. However, there is no head-to-head trial data or indirect comparison analyses between dexlansoprazole and esomeprazole. AIM To compare the efficacy of dexlansoprazole with esomeprazole in healing erosive oesophagitis (EO), the maintenance of healed EO and the treatment of non-erosive reflux… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 63 references

Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief

  • RN Zheng
  • Aliment Pharmacol Ther
  • 2013

Similar Papers

Loading similar papers…